China Biologic Privatization Transaction Led by Centurium Capital Wins AVCJ "Deal of the Year - Large Cap" Nov 16, 2021 10:11PM
Form SC 13D/A China Biologic Products Filed by: Temasek Holdings (Private) Ltd Apr 21, 2021 09:37AM
Form SC 13D/A China Biologic Products Filed by: Temasek Holdings (Private) Ltd Nov 23, 2020 09:32AM
China Biologic (CBPO) Enters into Definitive Merger Agreement for Going Private Transaction Valued at $4.76 Billion Nov 19, 2020 08:11AM
China Biologic Enters into Definitive Merger Agreement for Going Private Transaction Nov 19, 2020 08:09AM


Sep 18, 2020 06:44AM Form SC 13D/A China Biologic Products Filed by: Temasek Holdings (Private) Ltd
Feb 24, 2020 07:00AM Centurium Capital and Certain Other Investors File a Transaction Statement on Schedule 13E-3 with the U. S. Securities and Exchange Commission
Jan 24, 2020 07:58AM Form SC 13D/A China Biologic Products Filed by: Temasek Holdings (Private) Ltd
Sep 30, 2019 08:40AM Form SC 13D China Biologic Products Filed by: Temasek Holdings (Private) Ltd